# Implantable Microdevice for TNBC - Pilot Study

> **NCT05774886** · PHASE1 · WITHDRAWN · sponsor: **Dana-Farber Cancer Institute**

## Conditions studied

- Triple Negative Breast Cancer
- Breast Cancer Stage II
- Breast Cancer Stage III
- Breast Cancer
- Early Stage Triple-Negative Breast Carcinoma
- Breast Neoplasms
- Breast Carcinoma

## Interventions

- **COMBINATION_PRODUCT:** Implantable Microdevice (IMD)

## Key facts

- **NCT ID:** NCT05774886
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-05
- **Primary completion:** 2023-09-01
- **Final completion:** 2028-09-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** On hold
- **Last updated:** 2023-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05774886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05774886, "Implantable Microdevice for TNBC - Pilot Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05774886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*